Test Price
2,800 AED✅ Home Collection Available
ABCA4 Gene Cone-Rod Dystrophy Type 3 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل الجين ABCA4 لكشف الحثل المخروطي القضيبي من النوع 3 بتقنية التسلسل الجيني NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي:
يُقدَّم فحص تسلسل الحمض النووي لجين ABCA4 وفق أعلى معايير هيئة الصحة بدبي والقوانين الاتحادية لدولة الإمارات. دقة تشخيصية تصل إلى 99.9% عبر مختبر حاصل على شهادة ISO 9001:2015، مع خدمة سحب الدم المنزلي المبردة واستشارة جينية هاتفية بعد الفحص.
Executive Summary:
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: Hospital-Grade Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM - 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Genetic Counselling session with a DHA-licensed specialist.
- Insurance Billing: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Clinical Intelligence
يستهدف هذا الاختبار تحليل جين ABCA4 المسؤول عن الحثل المخروطي القضيبي من النوع الثالث. This targeted Genetic Test deciphers pathogenic variants in the ABCA4 gene, enabling definitive molecular diagnosis of cone-rod dystrophy type 3. It empowers ophthalmologists, genetic counsellors, and researchers with carrier screening and precise prognostic data, aligned with 2026 ACMG/AMP variant interpretation guidelines.
| Feature | Our ABCA4 NGS Test | Closest Alternative (WES) |
|---|---|---|
| Precision | 99.9% analytical sensitivity for ABCA4 coding exons ±20bp splice regions | Variable coverage; often requires orthogonal validation |
| Methodology | NGS with CNV calling & 2026 deep intronic analysis | Whole Exome Sequencing (may miss deep intronic variants) |
| Turnaround | 3 to 4 Weeks | 8–12 Weeks (with interpretation delays) |
| Clinical Report | DHA-compliant, includes pedigree integration & therapeutic eligibility | Generic VCF; often lacks ophthalmology-specific annotation |
Physician Insight & Clinical Safety Protocol
“Every ABCA4 result must be interpreted within the full clinical mosaic—electroretinography, fundus imaging, and family history. A positive test confirms molecular pathology; a negative one never excludes other retinal dystrophies. My team ensures your report empowers, not frightens, guiding you toward evidence-based ophthalmologic care and, where eligible, emerging gene therapy trials. — Dr. Prabhakar Reddy, DHA License: 61713011”
Medication Warning:
Do not discontinue any prescribed eye medication, vitamin supplements, or systemic therapy without consulting your supervising ophthalmologist or neurologist. Abrupt cessation can trigger irreversible vision loss.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusions: Active ocular infection, recent intraocular surgery (<4 weeks), inability to provide informed genetic consent (minors require guardian per CDS Law 2026).
- Emergency Flags: Sudden loss of vision, acute eye pain, photopsia for >5 minutes, or floaters with flashes—proceed directly to your emergency ophthalmologist, not this elective test.
- Data Safety: All genetic data is encrypted per UAE PDPL, stored on local servers; re-identification risk is legally minimized.
Who Benefits? Curated Clinical Intents
Ophthalmologist
Definitive genetic stratification for cone-rod dystrophy prognosis, monitoring, and future gene therapy candidacy assessment.
Medical & PhD Researchers
High-quality variant data for genotype-phenotype correlation studies, compliant with 2026 open-science ethics.
Legal Professionals & Individuals
Court-admissible genetic evidence for inheritance disputes and personal peace of mind under UAE law.
Patient FAQs & Clinical Guidance
Q: Why does this test require genetic counselling before and after the blood draw?
جلسة الاستشارة الجينية إلزامية لرسم شجرة العائلة وتفسير طفرات ABCA4 بدقة لتجنب النتائج الخاطئة. The pre-test counselling captures a detailed pedigree, assesses autosomal recessive inheritance patterns, and prepares you psychologically for the results. Post-test counselling translates the complex NGS report into actionable medical steps and family planning options, fully aligned with DHA’s 2026 genomics consent standards.
Q: Can this test be used for asymptomatic relatives or minors?
يمكن إجراء فحص الأقارب غير المصابين بعد بلوغ 18 سنة ووفقًا لقانون CDS 2026 لحماية القُصّر. Predictive testing for at-risk family members is permitted only with comprehensive genetic counselling and, for minors, a court order or explicit medical necessity as defined by UAE CDS Law 2026. Carrier screening for reproductive partners follows a separate DHA protocol.
Q: How does the 2800 AED price compare to international costs, and is insurance accepted?
السعر 2800 درهم إماراتي يشمل التحليل والتقرير الطبي المعتمد مع إمكانية التحقق المباشر من التأمين. This fee covers NGS library preparation, sequencing, bioinformatics, clinical report, and one post-test teleconsult. International labs often charge 1500–3000 USD. We offer direct insurance billing with most UAE networks; please verify via WhatsApp at +971 54 548 8731 prior to collection.
ABCA4 Cone-Rod Dystrophy Type 3 NGS, LOINC: 48006-5, ICD-10-CM: H35.54, Z13.5, Z14.8. Last reviewed: April 2026.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians